Genomics

Dataset Information

0

Gene expression profiling in AML with normal karyotype: A multicenter study investigating molecular markers in 251 cases


ABSTRACT: Acute myeloid leukemia (AML) is a heterogeneous disease and AML with normal karyotype (AML-NK) is categorized as an intermediate-risk group. Over the past years molecular analyses successfully identified biomarkers that will further allow to dissecting clinically meaningful subgroups in this disease. Thus far, somatic mutations were identified which elucidate the disturbance of cellular growth, proliferation, and differentiation processes in hematopoietic progenitor cells. In AML-NK, acquired gene mutations with prognostic relevance were identified for FLT3, CEBPA, and NPM1. FLT3-ITD mutations were associated with short relapse-free and overall survival, while mutations in CEBPA or NPM1 (without concomitant FLT3-ITD) had a more favorable outcome. Here, we present a multicenter study investigating gene expression profiles of 251 cases of AML-NK. In three centers whole-genome microarray analyses were performed to delineate robust and common expression signatures for molecular markers in AML-NK.

ORGANISM(S): Homo sapiens

PROVIDER: GSE15434 | GEO | 2010/01/01

SECONDARY ACCESSION(S): PRJNA115791

REPOSITORIES: GEO

Similar Datasets

| E-GEOD-15434 | biostudies-arrayexpress
| E-GEOD-16015 | biostudies-arrayexpress
| E-GEOD-8043 | biostudies-arrayexpress
| E-GEOD-30442 | biostudies-arrayexpress
2009-06-01 | GSE16015 | GEO
2011-12-16 | GSE30442 | GEO
2017-04-03 | GSE86021 | GEO
| E-GEOD-18018 | biostudies-arrayexpress
2008-02-28 | GSE8043 | GEO
| E-TABM-1208 | biostudies-arrayexpress